Updated:
Evergrande Health Group
Evergrande Health Group — Hui Ka Yan's listed healthcare subsidiary, now a distressed carve-out amid Evergrande's historic restructuring.
Evergrande Health Group
Evergrande Health Group was established as a Hong Kong-listed vehicle (HKEX: 0708) to consolidate the healthcare ambitions of Shenzhen-based China Evergrande Group under its founder and chairman, Hui Ka Yan. The entity originally formed part of a broader diversification push beyond core property development, alongside Evergrande Auto and Evergrande Property Services. Its mandate encompassed senior-care communities, hospital management, and wellness-focused real estate — branded largely under the 'Evergrande Health Valley' concept. Following Evergrande's 2021 default, the subsidiary's market capitalization collapsed and trading was suspended, leaving its standalone viability in question. The group's operational strategy depended on integrating healthcare services within large-scale, mixed-use development projects. Its flagship asset class was senior-living communities co-located with residential complexes, a model that combined health management and elderly care under a single operating company. The portfolio included the Boao Evergrande International Hospital in Hainan, a facility licensed before regulatory tightening on private hospitals, as well as multiple Health Valley sites in cities such as Sanya and Kunming. Investment posture relied almost entirely on parent-company funding, with minimal institutional co-investment or external limited partners. At the time of its peak, Evergrande Health employed a workforce embedded across Evergrande's regional property arms, though exact headcount was never disentangled from the parent. The firm maintained no separate, disclosed AUM, and its balance sheet was dominated by related-party receivables from China Evergrande, which became largely unrecoverable post-default. In early 2024, a Hong Kong court ordered the liquidation of the parent, Evergrande, after a failed restructuring negotiation — an event that effectively terminated any residual strategic control Hui Ka Yan maintained over healthcare operations. The liquidators now administer asset sales on behalf of creditors. Evergrande Health's structural differentiator is its status as a court-administered, publicly listed entity within a liquidation — an accidental structure nearly unique among healthcare platforms. Where most healthcare operators seek strategic buyers or IPO proceeds, Evergrande Health's assets are being unwound through a government-managed process, with the Communist Party's priority on social stability and elderly care access shaping the resolution. The fate of its unfinished hospitals and senior-care commitments now depends less on market dynamics than on provincial policy decisions and creditor hierarchies.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Guangzhou
Corporate office
Guangzhou, Guangdong, China
Principals
Hui Ka Yan
Chairman
Sector focus
Frequently asked questions
What is the relationship between Evergrande Health Group and China Evergrande Group?
Evergrande Health Group is a publicly listed subsidiary of China Evergrande Group, the property developer that defaulted on over $300 billion in liabilities in 2021. The healthcare arm was consolidated on Evergrande's balance sheet and funded predominantly through inter-company loans, which became unrecoverable after the parent's collapse. Following a Hong Kong liquidation order in January 2024, control of Evergrande Health's assets now rests with court-appointed liquidators rather than the founding Hui family.
Does Evergrande Health have operational assets generating independent revenue?
Its core operational assets include the Boao Evergrande International Hospital in Hainan and a portfolio of senior-living communities under the 'Evergrande Health Valley' brand. However, many projects were halted in early construction phases when the parent's liquidity crisis intensified, and the subsidiary never reported significant standalone, third-party revenue. The current revenue-generating capacity of the remaining assets is unclear and subject to liquidator assessment.
Who runs investment decisions at Evergrande Health now?
No independent investment committee operates at Evergrande Health. All material decisions — including asset sales, creditor negotiations, and operational funding — are directed by the liquidators appointed by the Hong Kong court, Alvarez & Marsal. Chairman Hui Ka Yan no longer exercises executive authority over the healthcare subsidiary, as he has been sidelined from the parent's restructuring process.
What investment stages or asset classes did Evergrande Health typically target?
The firm did not function as a traditional institutional investor targeting startups or third-party funds. Its model focused on direct, wholly owned development of large-scale healthcare real estate — primarily senior-living communities and private hospitals — integrated with parent-funded residential projects. It never made venture-stage healthcare investments or participated in limited partner fund commitments.
How are Evergrande Health's assets being wound down?
The liquidators are pursuing asset sales through a bilateral process with interested state-owned enterprises and regional healthcare operators rather than a transparent public auction. The Chinese government has indicated it will prioritize the continuation of elderly care services, potentially absorbing some facilities into provincial health systems. Creditors face severely impaired recovery rates given the seniority of domestic homebuyer and supplier claims over offshore debt.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: